Evidence map›Paper›PMID 40009287›Full record

ArticleNeuromolecular medicine2025

ADAR1 Promotes NUPR1 A-to-I RNA Editing to Exacerbate Ischemic Brain Injury by Microglia Mediated Neuroinflammation.

Guo-Ping Wang, Wen-Juan Li, Ye Li, Ming-Xing Ma, Kai-Kai Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Neuromolecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guo-Ping Wang *Department of Anesthesiology, Chang Zhi People's Hospital, 502 Chang Xing Middle Road, Chang Zhi, 046000, Shanxi, China.
Wen-Juan Li *Department of Anesthesiology, Chang Zhi People's Hospital, 502 Chang Xing Middle Road, Chang Zhi, 046000, Shanxi, China.
Ye Li *Department of Pain Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, 1000853, China.
Ming-Xing MaDepartment of Pain Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, 1000853, China. he9408778@163.com.
Kai-Kai GuoDepartment of Pain Medicine, the First Medical Center, Chinese PLA General Hospital, Beijing, 1000853, China. biguo075388s@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglial cells occupy a crucial position as potential therapeutic targets in the context of ischemic stroke (IS). Nonetheless, the intrinsic mechanisms that govern microglial activation in the aftermath of IS remain incompletely elucidated. ADAR1 p150 plays a significant role in immune regulation and stress responses; however, the specific pathways through which it modulates microglial activation and the subsequent mechanisms that unfold following IS have yet to be clearly delineated. The distal middle cerebral artery occlusion (dMCAO) mouse model was utilized to induce IS. The evaluation of infarct volume was conducted through TTC staining, while neurological function was assessed using the modified Neurological Severity Score (mNSS). To evaluate the expression of ADAR1 and apoptosis-related proteins, immunofluorescence and Western blot techniques were employed. BV2 cells were subjected to oxygen-glucose deprivation followed by reperfusion (OGD/R). Additionally, a co-culture system of BV2 cells and neurons was established, and subsequent assessments of neuronal viability and apoptosis were performed using CCK-8 assays and LDH release assays. ADAR1 p150 expression was significantly upregulated in the brains of ischemic mice, particularly within microglial cells. The overexpression of ADAR1 p150 was found to promote microglial activation and enhance pro-inflammatory responses, whereas the knockdown of ADAR1 p150 yielded the opposite effect. Additionally, the knockdown of ADAR1 p150 in microglia resulted in a marked reduction in neuronal apoptosis within the co-culture system. Rescue experiments indicated that the knockdown of NUPR1 partially reinstated the inflammatory response previously induced by ADAR1 p150 knockdown. Notably, ADAR1 p150 knockdown also inhibited A-to-I RNA editing while simultaneously upregulating NUPR1. Furthermore, the reduction of ADAR1 expression was associated with decreased infarct volume, improved neurological outcomes, and a significant attenuation of neuroinflammation in dMCAO mice. ADAR1 p150 enhances the microglial inflammatory response and neuronal apoptosis in IS by facilitating A to I RNA editing of NUPR1.

Indexed as

Adenosine DeaminaseBasic Helix-Loop-Helix ProteinsIschemic StrokeMicrogliaNeuroinflammatory DiseasesAnimalsApoptosisBrainCell LineCoculture TechniquesDisease Models, AnimalDNA-Binding ProteinsGene Expression RegulationHEK293 CellsHumansInfarction, Middle Cerebral ArteryADAR1 protein, mouseAdenosine DeaminaseBasic Helix-Loop-Helix ProteinsDNA-Binding ProteinsNeoplasm ProteinsNupr1 protein, mouseADAR1Ischemic strokeMicrogliaNeuroinflammationNeuron apoptosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.